miRNAs and SAMHD1 regulation in vitro and in a model of HIV CNS disease by unknown
LETTER TO THE EDITOR Open Access
miRNAs and SAMHD1 regulation in vitro
and in a model of HIV CNS disease
Kenneth W. Witwer* , Erin L. Buchanan, Stephanie L. Myers and Melissa A. McAlexander
Abstract
Pilakka-Kanthikeel et al. recently reported higher levels of the retroviral restriction factor sterile alpha motif and
histidine/aspartic acid domain-containing protein 1 (SAMHD1) in astrocytes than in microglia, suggesting that
SAMHD1 levels might explain in part the relatively refractory nature of astrocytes to retroviral replication. These
findings are consistent with our studies of simian and human immunodeficiency virus infection of astrocytes and
macrophages. Similarly, a role for two host microRNAs in post-transcriptional regulation of SAMHD1 agrees with our
in vitro results and those of others. However, data from an animal model of HIV neurologic disorders may not be
consistent with robust miRNA-mediated regulation of SAMHD1 in vivo.
Letter to the editor
We were pleased to read the recent article of Pilakka-
Kanthikeel and colleagues, reporting higher levels of the
retroviral restriction factor sterile alpha motif and histidine/
aspartic acid domain-containing protein 1 (SAMHD1) in
astrocytes than in microglia [1]. The data suggest that
SAMHD1 levels might explain in part the relatively refrac-
tory nature of astrocytes to retroviral replication. These
findings are consistent with our studies of simian and hu-
man immunodeficiency virus (SIV and HIV) infection of
astrocytes and macrophages ([2], "Regulation of the
SAMHD1 transcript during retroviral infection of the cen-
tral nervous system," submitted); see also the different re-
sults on SAMHD1 in elite suppressor populations [3-5].
Similarly, a role for two host microRNAs (miRNAs) in
post-transcriptional regulation of SAMHD1 agrees with
our results [2] and Swaminathan et al. [6].
At the same time, we are somewhat uncertain about
the extent to which these miRNAs regulate SAMHD1 in
vivo. Pilakka-Kanthikeel et al. transfected 50 nM miR-
155 and miR-181 mimic or inhibitor and observed ef-
fects on SAMHD1 levels in cultured astrocytes [1]. In
our hands, 10 nM miR-155 and miR-181—as well as sev-
eral others including miR-34a and miR-150—reduced
the expression of luciferase reporters fused to the
SAMHD1 3′ untranslated region (3′ UTR), supporting
direct regulation (Fig. 1a). However, the stoichiometries
of these “all or nothing” assays are highly artificial, with
exposures amounting to millions or tens of millions of
oligonucleotides per cell. Additionally, and as reported
previously by others [7], we observed significant cell
death with miR-181a transfection, a potential explan-
ation for the particularly large reduction in this condi-
tion. The authors did not report viability in their
populations, but we wonder if this could explain some of
the observed effects.
Seeking to determine whether there is a tissue-level, in
vivo correlation between SAMHD1 and miRNAs found
to regulate the transcript in vitro, we measured SAMHD1
and miRNA expression in a well-characterized simian
model of HIV disease [8], including uninfected controls.
In the model, thalamic SAMHD1 expression increased
significantly after infection (p < 0.03), while miR-181a was
significantly downregulated (p < 0.001). This regulation in
opposite directions could be interpreted as consistent with
a miR-181a-SAMHD1 interaction. However, further ana-
lysis revealed no correlation of miR-181a and SAMHD1 in
any of the following groups: acute phase infection (Fig. 1b),
progression to disease (Fig. 1c), or all samples, including
uninfected controls (Fig. 1d). There was also no correlation
of SAMHD1 with levels of miR-155 or miR-34a, which in
fact tended to increase during infection (data not shown).
These results recall a previous finding in which the RNA
binding protein ZFP36 (tristetraprolin) could be sup-
pressed by miRNAs in vitro but showed little evidence of
negative correlation with the same miRNAs in vivo [9].
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While our findings temper our initial enthusiasm about
miRNA-mediated control of SAMHD1, we are not pre-
pared to dismiss it entirely. Although the astrocyte is the
most abundant cell type in the brain and appears to sup-
port higher levels of SAMHD1 expression than, e.g., mac-
rophages ["Regulation of the SAMHD1 transcript during
retroviral infection of the central nervous system," submit-
ted] and microglia [1], the tissue-level profiling we per-
formed may mask changes of miRNA or SAMHD1
expression in specific cells types or even the absence of
certain miRNAs in disease-related cells [10]. Similarly, fo-
cusing on single miRNA-to-target interactions ignores the
regulatory “whole picture,” since a given miRNA-to-target
interaction is governed not only by the abundance of each
partner but also by the abundance of other partners [11].
Finally, assuming adequate delivery methods, therapeutic
antisense manipulation of anti-SAMHD1 miRNAs (for
example, to help prevent cell-to-cell transmission during
eradication therapy) could be performed at high concen-
trations not dissimilar to the in vitro manipulations that
we and the authors performed. There may will be more to
learn about miRNAs and SAMHD1 in the CNS.
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